These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29937900)

  • 21. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
    Calmy A; Klement E; Teck R; Berman D; Pécoul B; Ferradini L
    AIDS; 2004 Dec; 18(18):2353-60. PubMed ID: 15622311
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative financing analysis and political economy of noncommunicable diseases.
    Jakovljevic M; Jakab M; Gerdtham U; McDaid D; Ogura S; Varavikova E; Merrick J; Adany R; Okunade A; Getzen TE
    J Med Econ; 2019 Aug; 22(8):722-727. PubMed ID: 30913928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Building reliable supply chains for noncommunicable disease commodities: lessons learned from HIV and evidence needs.
    Pastakia SD; Tran DN; Manji I; Wells C; Kinderknecht K; Ferris R
    AIDS; 2018 Jul; 32 Suppl 1():S55-S61. PubMed ID: 29952791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral load testing in resource-limited settings.
    Schooley RT
    Clin Infect Dis; 2007 Jan; 44(1):139-40. PubMed ID: 17143830
    [No Abstract]   [Full Text] [Related]  

  • 25. Public health. Global HIV/AIDS policy in transition.
    Bongaarts J; Over M
    Science; 2010 Jun; 328(5984):1359-60. PubMed ID: 20538936
    [No Abstract]   [Full Text] [Related]  

  • 26. Synergies in the fights against HIV/AIDS and against noncommunicable diseases in Africa.
    Milleliri JM
    Med Sante Trop; 2018 Nov; 28(4):341-342. PubMed ID: 30799813
    [No Abstract]   [Full Text] [Related]  

  • 27. HIV and noncommunicable diseases: a case for health system building.
    Oti SO
    Curr Opin HIV AIDS; 2013 Jan; 8(1):65-9. PubMed ID: 23143141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring antiretroviral therapy in resource-limited settings: balancing clinical care, technology, and human resources.
    Hosseinipour MC; Schechter M
    Curr HIV/AIDS Rep; 2010 Aug; 7(3):168-74. PubMed ID: 20499290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of mother-to-child transmission services as a gateway to family-based human immunodeficiency virus care and treatment in resource-limited settings: rationale and international experiences.
    Abrams EJ; Myer L; Rosenfield A; El-Sadr WM
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S101-6. PubMed ID: 17825640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noncommunicable Diseases Burden and Risk Factors in a Cohort of HIV+ Elderly Patients in Malawi.
    Ciccacci F; Tolno VT; Doro Altan AM; Liotta G; Orlando S; Mancinelli S; Palombi L; Marazzi MC
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1106-1111. PubMed ID: 31468993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Report from the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Early ART initiation improves survival in resource-limited settings.
    Friedland GH
    J Watch AIDS Clin Care; 2009 Oct; 21(10):79. PubMed ID: 20461842
    [No Abstract]   [Full Text] [Related]  

  • 32. Understanding the contribution of common childhood illnesses and opportunistic infections to morbidity and mortality in children living with HIV in resource-limited settings.
    Modi S; Chiu A; Ng'eno B; Kellerman SE; Sugandhi N; Muhe L;
    AIDS; 2013 Nov; 27 Suppl 2(0 2):S159-67. PubMed ID: 24361625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer in resource-limited settings.
    Krown SE
    J Acquir Immune Defic Syndr; 2011 Apr; 56(4):297-9. PubMed ID: 21350363
    [No Abstract]   [Full Text] [Related]  

  • 34. Trends and predictors of non-communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil.
    Castilho JL; Escuder MM; Veloso V; Gomes JO; Jayathilake K; Ribeiro S; Souza RA; Ikeda ML; de Alencastro PR; Tupinanbas U; Brites C; McGowan CC; Grangeiro A; Grinsztejn B
    J Int AIDS Soc; 2019 Jan; 22(1):e25233. PubMed ID: 30697950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Médecins Sans Frontières (MSF) antiretroviral treatment projects worldwide.
    GMHC Treat Issues; 2003; 17(7-8):7. PubMed ID: 14686313
    [No Abstract]   [Full Text] [Related]  

  • 36. Monitoring HIV treatment in resource-limited settings: reassuring news on the usefulness of CD4(+) cell counts.
    Fowler MG; Owor M
    J Infect Dis; 2009 May; 199(9):1255-7. PubMed ID: 19317627
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of cryptococcal meningitis in sub-saharan Africa.
    Jackson A; Hosseinipour MC
    Curr HIV/AIDS Rep; 2010 Aug; 7(3):134-42. PubMed ID: 20532838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capacity of Ugandan public sector health facilities to prevent and control non-communicable diseases: an assessment based upon WHO-PEN standards.
    Rogers HE; Akiteng AR; Mutungi G; Ettinger AS; Schwartz JI
    BMC Health Serv Res; 2018 Aug; 18(1):606. PubMed ID: 30081898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early initiation of antiretroviral therapy and universal HIV testing in sub-Saharan Africa: has WHO offered a milestone for HIV prevention?
    Menon S
    J Public Health Policy; 2010 Dec; 31(4):385-400. PubMed ID: 21119646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivering pediatric HIV care in resource-limited settings: cost considerations in an expanded response.
    Tolle MA; Phelps BR; Desmond C; Sugandhi N; Omeogu C; Jamieson D; Ahmed S; Reuben E; Muhe L; Kellerman SE;
    AIDS; 2013 Nov; 27 Suppl 2():S179-86. PubMed ID: 24361627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.